Chronic/Non-Infectious Disease — United States
Sanofi Genzyme on [Mon 11 Dec 2017] told doctors and pharmacists to return more than 12 000 syringes filled with an injectable arthritis gel because it was contaminated, as the Cambridge-based biotech elevated its “product hold” of last week to a recall. A lot containing 18 000 gel-filled syringes of Sinvisc-One [sic] tested positive for microbial contamination, said Ashleigh Koss, a spokeswoman for the company’s French parent, Sanofi SA. Only 12 380 of the syringes were distributed, all in
…
